Yan Ding
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Renal and related cancers
- Angiogenesis and VEGF in Cancer
- Ubiquitin and proteasome pathways
- Bacillus and Francisella bacterial research
Papers in
-
- Renal and related cancers 5
- Melanoma and MAPK Pathways 3
-
- Renal cell carcinoma treatment 7
- Ferroptosis and cancer prognosis 4
- Co-authors
- Dan Huang (7 shared papers)Bin Tean Teh (6 shared papers)Chao-Nan Qian (3 shared papers)David Petillo (3 shared papers)Kristin VandenBeldt (2 shared papers)Wang-Mei Luo (2 shared papers)Kyle A. Furge (3 shared papers)P. Andrew Futreal (2 shared papers)
- Journals
- Cancer Research (5 papers)Cell Death and Differentiation (2 papers)Acta Biochimica et Biophysica Sinica (2 papers)Cell Death and Disease (2 papers)Cell Death Discovery (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yan Ding
49 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 294
- Molecular Biology 857
- Pulmonary and Respiratory Medicine 355
- Oncology 274
- Cell Biology 155
Countries citing papers authored by Yan Ding
This map shows the geographic impact of Yan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ding more than expected).
Fields of papers citing papers by Yan Ding
This network shows the impact of papers produced by Yan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ding. The network helps show where Yan Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 346 | |
| 2 | 2010 | 191 | |
| 3 | 2008 | 180 | |
| 4 | 2008 | 105 | |
| 5 | 2012 | 84 | |
| 6 | 2019 | 74 | |
| 7 | VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma. | 2010 | 47 |
| 8 | 2017 | 38 | |
| 9 | 2006 | 35 | |
| 10 | 2008 | 33 | |
| 11 | 2022 | 33 | |
| 12 | 2020 | 33 | |
| 13 | 2008 | 31 | |
| 14 | 2011 | 31 | |
| 15 | 2016 | 31 | |
| 16 | 2019 | 29 | |
| 17 | 2018 | 22 | |
| 18 | 2023 | 21 | |
| 19 | 2007 | 21 | |
| 20 | 2020 | 21 |
About Yan Ding
Yan Ding is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Endocrine and Autonomic Systems, Cancer Research and Oncology, having authored 52 papers that have together received 1.7k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (7 papers), Neuroscience of respiration and sleep (6 papers), Renal and related cancers (5 papers), Ferroptosis and cancer prognosis (4 papers), Cancer Mechanisms and Therapy (3 papers), Melanoma and MAPK Pathways (3 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (294 citations), Molecular Biology (857 citations), Pulmonary and Respiratory Medicine (355 citations), Oncology (274 citations) and Cell Biology (155 citations). Yan Ding has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Dan Huang, Bin Tean Teh, Chao-Nan Qian, David Petillo, Kristin VandenBeldt, Wang-Mei Luo, Kyle A. Furge, P. Andrew Futreal, Brian I. Rini and Ming Zhou. Their work appears in journals such as Cancer Research, Cell Death and Differentiation, Acta Biochimica et Biophysica Sinica, Cell Death and Disease and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.